TAM
IOVA icon

Tocqueville Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Tocqueville Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-171,290
Closed -$2.85M – 688
2022
Q1 		$2.85M Buy
171,290
+30,350
+22% +$469K 0.04% 306
2021
Q4 		$2.69M Sell
140,940
-8,400
-6% -$185K 0.04% 343
2021
Q3 		$3.68M Sell
149,340
-12,750
-8% -$300K 0.05% 290
2021
Q2 		$4.22M Buy
162,090
+68,500
+73% +$1.78M 0.06% 280
2021
Q1 		$2.96M Sell
93,590
-1,860
-2% -$77.1K 0.05% 321
2020
Q4 		$4.43M Buy
95,450
+60,450
+173% +$2.4M 0.07% 247
2020
Q3 		$1.15M Hold
35,000
– – 0.02% 384
2020
Q2 		$961K Hold
35,000
– – 0.02% 396
2020
Q1 		$1.05M Sell
35,000
-25,000
-42% -$663K 0.03% 349
2019
Q4 		$1.66M Sell
60,000
-68,605
-53% -$1.56M 0.02% 377
2019
Q3 		$2.34M Buy
128,605
+1,550
+1% +$34.3K 0.03% 357
2019
Q2 		$3.12M Buy
127,055
+82,930
+188% +$1.25M 0.04% 347
2019
Q1 		$420K Buy
44,125
+17,300
+64% +$168K 0.01% 618
2018
Q4 		$237K Buy
26,825
+3,000
+13% +$28.9K ﹤0.01% 669
2018
Q3 		$268K Sell
23,825
-1,100
-4% -$15.6K ﹤0.01% 712
2018
Q2 		$319K Buy
24,925
+14,100
+130% +$206K ﹤0.01% 680
2018
Q1 		$183K Buy
+10,825
New +$164K ﹤0.01% 795
2017
Q2 		– Sell
-23,000
Closed -$171K – 814
2017
Q1 		$171K Hold
23,000
– – ﹤0.01% 767
2016
Q4 		$160K Hold
23,000
– – ﹤0.01% 769
2016
Q3 		$189K Buy
+23,000
New +$195K ﹤0.01% 784

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Tocqueville Asset Management's IOVA Position: Q2 2022 in Review

Tocqueville Asset Management sold out of Iovance Biotherapeutics (IOVA) in Q2 2022, closing a stake of 171,290 shares — an estimated $2.85M sold.

Tocqueville Asset Management first reported a position in IOVA in Q3 2016 and held it in 20 quarters. The position peaked at $4.43M in Q4 2020. 237 funds tracked by Wall St. Rank hold IOVA as of Q2 2022.

  • Tocqueville Asset Management reported no remaining Iovance Biotherapeutics position as of Q2 2022 after selling out during the quarter.
  • Tocqueville Asset Management sold 171,290 Iovance Biotherapeutics shares in Q2 2022, an estimated $2.85M.
  • Tocqueville Asset Management first reported a position in Iovance Biotherapeutics in Q3 2016 and held it in 20 quarters.
  • Tocqueville Asset Management's Iovance Biotherapeutics position peaked at $4.43M in Q4 2020.
  • 237 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2022.

Based on Tocqueville Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.